Gurus BioPharm LLC (“Gurus”) is a research company developing innovative drugs. We develop groundbreaking Russian biopharmaceutical innovations from the early stages to commercialization at the global market.

We develop innovative drugs to restore the human health and quality of life in chronic diseases. We believe in the great potential of the Russian science and contribute to the creation of a new Russian innovative economy. We help scientists to turn their idea into a drug. We offer the projects in the most profitable and fastest growing industry in the world for investors. Our business unites these aspirations.

Gurus BioPharm was founded in 2011 by enthusiasts which have industrial, scientific and commercial experience, and who dreamed of creating a mechanism for commercializing Russian biopharmaceutical projects.
In 2005 Igor Teterin founded a consulting company Gurus which started to performed M&A transactions and capital raising for small and middle companies, later Gurus started to lead consulting projects for pharmaceutical companies on valuation of drug candidates, due diligence, business valuation, and marketing research of the pharmaceutical market.
In 2008 Igor Lyubimov completed work at the government research institute and continued his career with private life sciences investment firms and pharmaceutical contract research organizations on managerial positions.
In late 2010, our ways crossed and we united into a one team.